BibTex format
@article{Lyon:2020:10.1002/ejhf.1920,
author = {Lyon, AR and Dent, S and Stanway, S and Earl, H and Brezden-Masley, C and Cohen-Solal, A and Tocchetti, CG and Moslehi, JJ and Groarke, JD and Bergler-Klein, J and Khoo, V and Tan, LL and Anker, MS and von, Haehling S and Maack, C and Pudil, R and Barac, A and Thavendiranathan, P and Ky, B and Neilan, TG and Belenkov, Y and Rosen, SD and Iakobishvili, Z and Sverdlov, AL and Hajjar, LA and Macedo, AVS and Manisty, C and Ciardiello, F and Farmakis, D and de, Boer RA and Skouri, H and Suter, TM and Cardinale, D and Witteles, RM and Fradley, MG and Herrmann, J and Cornell, RF and Wechelaker, A and Mauro, MJ and Milojkovic, D and de, Lavallade H and Ruschitzka, F and Coats, AJS and Seferovic, PM and Chioncel, O and Thum, T and Bauersachs, J and Andres, MS and Wright, DJ and Lopez-Fernandez, T and Plummer, C and Lenihan, D},
doi = {10.1002/ejhf.1920},
journal = {EUROPEAN JOURNAL OF HEART FAILURE},
pages = {1945--1960},
title = {Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety},
url = {http://dx.doi.org/10.1002/ejhf.1920},
volume = {22},
year = {2020}
}